COMPLETE TEST BANK FOR
PHARMACOLOGY: A PATIENT-
CENTERED NURSING PROCESS
APPROACH 12TH EDITION
BY LINDA E. MCCUISTION PHD
MSN RN KATHLEEN VULJOIN
DIMAGGIO MSN
||NEWEST VERSION {2024 – 2025}
,UNIT I: INTRODUCTION TO PHARMACOLOGY
CHAPTER 1. CLINICAL JUDGMENT MEASUREMENT
MODEL AND THE NURSING PROCESS
CHAPTER 2. DRUG DEVELOPMENT AND ETHICAL
CONSIDERATIONS CHAPTER 3.
PHARMACOKINETICS AND
PHARMACODYNAMICS CHAPTER 4.
PHARMACOGENETICS
CHAPTER 5. COMPLEMENTARY AND
ALTERNATIVE THERAPIES CHAPTER 6.
PEDIATRIC CONSIDERATIONS
CHAPTER 7. GERIATRIC CONSIDERATIONS
CHAPTER 8. DRUGS IN SUBSTANCE USE DISORDER
UNIT II: PHARMACOTHERAPY AND DRUG
ADMINISTRATION
CHAPTER 9. SAFETY AND
QUALITY CHAPTER 10. DRUG
ADMINISTRATION
CHAPTER 11. DRUG LABELS AND DOSAGE
CALCULATIONS
UNIT III: MAINTENANCE OF
HOMEOSTASIS CHAPTER 12. FLUID
VOLUME AND ELECTROLYTES CHAPTER
13. VITAMIN AND MINERAL
REPLACEMENT CHAPTER 14.
NUTRITIONAL SUPPORT
UNIT IV: AUTONOMIC NERVOUS
SYSTEM DRUGS CHAPTER 15.
ADRENERGIC AGONISTS AND ANTAGONISTS
CHAPTER 16. CHOLINERGIC AGONISTS AND
ANTAGONISTS
UNIT V: CENTRAL AND PERIPHERAL NERVOUS
SYSTEM DRUGS
CHAPTER 17. STIMULANTS
CHAPTER 18.
,DEPRESSANTS CHAPTER
19. ANTISEIZURE DRUGS
CHAPTER 20. DRUGS FOR PARKINSONISM AND
ALZHEIMER’S DISEASE CHAPTER 21. DRUGS FOR
NEUROMUSCULAR DISORDERS AND MUSCLE SPASMS
UNIT VI: MENTAL AND BEHAVIORAL HEALTH
DRUGS
CHAPTER 22. ANTIPSYCHOTICS AND
ANXIOLYTICS CHAPTER 23.
ANTIDEPRESSANTS AND MOOD
STABILIZERS
, UNIT VII: PAIN AND INFLAMMATION
MANAGEMENT DRUGS
CHAPTER 24. ANTIINFLAMMATORIES
CHAPTER 25. ANALGESICS
UNIT VIII: ANTIMICROBIAL DRUGS
CHAPTER 26. PENICILLINS, OTHER BETA-LACTAMS,
AND CEPHALOSPORINS CHAPTER 27. MACROLIDES,
OXAZOLIDINONES, LINCOSAMIDES, GLYCOPEPTIDES,
KETOLIDES, AND LIPOPEPTIDES
CHAPTER 28. TETRACYCLINES, GLYCYLCYCLINES,
AMINOGLYCOSIDES, AND FLUOROQUINOLONES
CHAPTER 29. SULFONAMIDES AND
NITROIMIDAZOLES ANTIBIOTICS CHAPTER 30.
ANTITUBERCULARS, ANTIFUNGALS, AND
ANTIVIRALS CHAPTER 31. ANTIMALARIALS,
ANTHELMINTICS, AND PEPTIDES
UNIT IX: IMMUNOLOGIC
DRUGS CHAPTER 32. HIV- AND
AIDS-RELATED DRUGS CHAPTER
33. TRANSPLANT DRUGS
CHAPTER 34. VACCINES
UNIT X: ANTINEOPLASTICS AND BIOLOGIC
RESPONSE MODIFIERS
CHAPTER 35. ANTICANCER DRUGS
CHAPTER 36. TARGETED THERAPIES TO
TREAT CANCER CHAPTER 37. BIOLOGIC
RESPONSE MODIFIERS
UNIT XI: RESPIRATORY
DRUGS CHAPTER 38. UPPER
RESPIRATORY DISORDERS
CHAPTER 39. LOWER
RESPIRATORY DISORDERS
UNIT XII: CARDIOVASCULAR DRUGS
CHAPTER 40. CARDIAC GLYCOSIDES, ANTIANGINALS,
PHARMACOLOGY: A PATIENT-
CENTERED NURSING PROCESS
APPROACH 12TH EDITION
BY LINDA E. MCCUISTION PHD
MSN RN KATHLEEN VULJOIN
DIMAGGIO MSN
||NEWEST VERSION {2024 – 2025}
,UNIT I: INTRODUCTION TO PHARMACOLOGY
CHAPTER 1. CLINICAL JUDGMENT MEASUREMENT
MODEL AND THE NURSING PROCESS
CHAPTER 2. DRUG DEVELOPMENT AND ETHICAL
CONSIDERATIONS CHAPTER 3.
PHARMACOKINETICS AND
PHARMACODYNAMICS CHAPTER 4.
PHARMACOGENETICS
CHAPTER 5. COMPLEMENTARY AND
ALTERNATIVE THERAPIES CHAPTER 6.
PEDIATRIC CONSIDERATIONS
CHAPTER 7. GERIATRIC CONSIDERATIONS
CHAPTER 8. DRUGS IN SUBSTANCE USE DISORDER
UNIT II: PHARMACOTHERAPY AND DRUG
ADMINISTRATION
CHAPTER 9. SAFETY AND
QUALITY CHAPTER 10. DRUG
ADMINISTRATION
CHAPTER 11. DRUG LABELS AND DOSAGE
CALCULATIONS
UNIT III: MAINTENANCE OF
HOMEOSTASIS CHAPTER 12. FLUID
VOLUME AND ELECTROLYTES CHAPTER
13. VITAMIN AND MINERAL
REPLACEMENT CHAPTER 14.
NUTRITIONAL SUPPORT
UNIT IV: AUTONOMIC NERVOUS
SYSTEM DRUGS CHAPTER 15.
ADRENERGIC AGONISTS AND ANTAGONISTS
CHAPTER 16. CHOLINERGIC AGONISTS AND
ANTAGONISTS
UNIT V: CENTRAL AND PERIPHERAL NERVOUS
SYSTEM DRUGS
CHAPTER 17. STIMULANTS
CHAPTER 18.
,DEPRESSANTS CHAPTER
19. ANTISEIZURE DRUGS
CHAPTER 20. DRUGS FOR PARKINSONISM AND
ALZHEIMER’S DISEASE CHAPTER 21. DRUGS FOR
NEUROMUSCULAR DISORDERS AND MUSCLE SPASMS
UNIT VI: MENTAL AND BEHAVIORAL HEALTH
DRUGS
CHAPTER 22. ANTIPSYCHOTICS AND
ANXIOLYTICS CHAPTER 23.
ANTIDEPRESSANTS AND MOOD
STABILIZERS
, UNIT VII: PAIN AND INFLAMMATION
MANAGEMENT DRUGS
CHAPTER 24. ANTIINFLAMMATORIES
CHAPTER 25. ANALGESICS
UNIT VIII: ANTIMICROBIAL DRUGS
CHAPTER 26. PENICILLINS, OTHER BETA-LACTAMS,
AND CEPHALOSPORINS CHAPTER 27. MACROLIDES,
OXAZOLIDINONES, LINCOSAMIDES, GLYCOPEPTIDES,
KETOLIDES, AND LIPOPEPTIDES
CHAPTER 28. TETRACYCLINES, GLYCYLCYCLINES,
AMINOGLYCOSIDES, AND FLUOROQUINOLONES
CHAPTER 29. SULFONAMIDES AND
NITROIMIDAZOLES ANTIBIOTICS CHAPTER 30.
ANTITUBERCULARS, ANTIFUNGALS, AND
ANTIVIRALS CHAPTER 31. ANTIMALARIALS,
ANTHELMINTICS, AND PEPTIDES
UNIT IX: IMMUNOLOGIC
DRUGS CHAPTER 32. HIV- AND
AIDS-RELATED DRUGS CHAPTER
33. TRANSPLANT DRUGS
CHAPTER 34. VACCINES
UNIT X: ANTINEOPLASTICS AND BIOLOGIC
RESPONSE MODIFIERS
CHAPTER 35. ANTICANCER DRUGS
CHAPTER 36. TARGETED THERAPIES TO
TREAT CANCER CHAPTER 37. BIOLOGIC
RESPONSE MODIFIERS
UNIT XI: RESPIRATORY
DRUGS CHAPTER 38. UPPER
RESPIRATORY DISORDERS
CHAPTER 39. LOWER
RESPIRATORY DISORDERS
UNIT XII: CARDIOVASCULAR DRUGS
CHAPTER 40. CARDIAC GLYCOSIDES, ANTIANGINALS,
